Xiang Liao
Fortune : 160 278 $ au 31/08/2026
Fortune : 160 278 $ au 31/08/2026
Xiang Liao is Chief Executive Officer at Novastream Biotech Co. Ltd. since 2012 and Independent Non-Executive Director at Clover Biopharmaceuticals Ltd. since 2021.
Formerly, Mr. Liao was Director-Corporate Development at Sanofi Pasteur SA from 1992 to 2007.
Education includes an MBA from The Trustees of Columbia University in The City of New York (2003), a graduate degree from the University of Scranton (1992), and an undergraduate degree from West China University of Medical Sciences (1987).
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/04/2026 | 607 000 ( 0,05 % ) | 160 278 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Directeur/Membre du Conseil | 19/04/2021 |
Novastream Biotech Co. Ltd. | Directeur Général | 01/03/2012 |
| Sociétés | Poste | Fin |
|---|---|---|
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Manufactures and supplies vaccines | Corporate Officer/Principal | 01/12/2007 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Scranton
University of Scranton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West China University of Medical Sciences
West China University of Medical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Manufactures and supplies vaccines | Health Technology |
Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Novastream Biotech Co. Ltd. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national